August 9, 2021 Lab Top-10

Thermo Fisher Scientific Announces Offering of USD-Denominated Senior Notes

WALTHAM, Mass., Aug. 9, 2021 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”) announced today that it intends to offer USD-denominated senior notes. Thermo Fisher intends to use the net proceeds of the Offering to pay a portion of the cash consideration payable for the pending acquisition of PPD, Inc., a Delaware corporation. The joint... Read more

August 9, 2021 Life Science Tools

GE Healthcare Brings Radiology Without Walls to Resource-Constrained Small Imaging Centers With AI-Enabled, Cloud Imaging Solution

GE Healthcare Brings Radiology Without Walls to Resource-Constrained Small Imaging Centers With AI-Enabled, Cloud Imaging Solution ·       Edison True PACS[1] is a transformative system, offering AI-enabled decision support to help radiologists adapt to higher workloads and increased exam complexity, and improve diagnostic accuracy ·       Innovative, cloud-based system removes barriers to adopting new diagnostic radiology efficiency... Read more

August 9, 2021 Lab Top-10

Thermo Fisher Scientific Updates Customizable TaqMan SARS-CoV-2 Mutation Panel to Detect Delta and Lambda Variants

Thermo Fisher Scientific Updates Customizable TaqMan SARS-CoV-2 Mutation Panel to Detect Delta and Lambda Variants CARLSBAD, Calif., Aug. 9, 2021 /PRNewswire/ — Thermo Fisher Scientific, the world leader in serving science, today announced it has updated its Applied Biosystems TaqMan SARS-CoV-2 Mutation Panel to detect the Delta and Lambda strains. First launched in March 2021,... Read more

August 9, 2021 Bio/Pharma/CRO PAI Top-10

[Ad hoc announcement pursuant to Art. 53 LR] Phase III study shows Roche's Polivy plus R-CHP is the first regimen in 20 years to significantly improve outcomes in previously untreated aggressive form of lymphoma compared to standard of care

Pivotal phase III POLARIX trial comparing Polivy in combination with chemotherapy regimen R-CHP versus the standard of care R-CHOP in treatment of first-line diffuse large B-cell lymphoma (DLBCL) met its primary endpoint of investigator-assessed progression-free survival Prolonging survival without disease advancement could be transformative for newly diagnosed DLBCL patients as currently 40% of patients relapse... Read more

August 6, 2021 Environ, Ag./Food & Bev Mass Spectrometry Product Launch

LC/MS/MS Method Package for Mycotoxins

For LabSolutions LCMS Mycotoxins are highly toxic chemical byproducts from fungi commonly found in crops, and residual content in foods are regulated all over the world. This method package provides simultaneous multi-component analysis conditions for mycotoxins subject to the regulations in Japan, the USA, the EU, and China. Analytical Methods for 27 Mycotoxins This package... Read more

August 6, 2021 Lab Equipment Product Launch

Pre-dispersion like a Pro

06 Aug 2021 Chemical Industry With the new NETZSCH ProPhi pre-grinding unit, a significant increase in production capacity with excellent reproducibility as well as enormous energy savings are achieved. A pre-mill fulfills the task of grinding coarse feed material that is difficult to handle in a standard mill. Pre-dispersion of agglomerates, which is usually done batchwise or continuously... Read more

August 6, 2021 Lab Top-10

Bruker Announces Quarterly Dividend

BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced that its Board of Directors has approved payment of a quarterly cash dividend in the amount of $0.04 per share on the Company’s common stock. The dividend will be paid on September 17, 2021 to stockholders of record as of September 1, 2021. About Bruker Corporation... Read more